| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 14, 2026 | Grant(A) | 170K | — | $0 | 170K |
Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-26-068917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Unicycive Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.